相关实验视频

Updated: Sep 17, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

缺乏LSP1会增加IL-17表达的T细胞,并加快原发性Sjögren综合征的发生

Jayhyun Kim¹, Jung Gon Kim², Yingjin Li³

¹Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea; Department of Biomedicine & Health Sciences, The Catholic University of Korea, Seoul, Republic of Korea.

Clinical immunology (Orlando, Fla.)

|June 30, 2025

概括

淋巴细胞特异性蛋白-1 (LSP1) 缺乏通过促进T-辅助者17 (Th17) 细胞发育,加剧了Sjögren综合征. 降低T细胞中的LSP1与老鼠模型和人类患者的疾病严重程度增加有关.

科学领域:

免疫学免疫学免疫学
自免疫性疾病自免疫性疾病

背景情况:

淋巴细胞特异性蛋白-1 (LSP1) 被公认为其在负面调节T细胞迁移中的作用.
在T细胞依赖性Sjögren综合征 (SjS) 的发病过程中,LSP1的特定功能以前没有被阐明.

研究的目的:

研究LSP1在实验性Sjögren综合征的发展和进展中的作用.
探索LSP1表达,T细胞反应和Sjögren综合征疾病严重程度之间的相关性.

主要方法:

从野生类型 (WT) 和Lsp1淘汰赛 (Lsp1-/-) 鼠对T细胞中的LSP1表达的比较分析与实验性SjS.
在小鼠模型中评估白细胞透到唾液腺 (SG).
在宫淋巴结和SG中的IL-17A表达T细胞的量化.
从人类原发性Sjögren综合征 (pSS) 患者的T细胞中分析LSP1表达和Th17细胞频率.

主要成果:

实验性SjS小鼠的SG内T细胞中的LSP1表达显著下降,与增强的白细胞透相关.
与WT小鼠相比,Lsp1-/-小鼠表现出产生IL-17A的T细胞的频率更高,并增加了SG的疾病严重程度.
在人类pSS患者的T细胞中观察到LSP1表达的减少和Th17细胞群的增加,显示出反向相关性.

结论:

缺少LSP1促进了Th17细胞的发育,导致Sjögren综合征的恶化.
在SjS中,LSP1在调节T细胞反应和疾病进展方面发挥着关键作用.
LSP1代表了一个潜在的治疗点,用于调节Th17反应和治疗像pSS.pSS这样的自身免疫性疾病.

关键词:

实验性Sjögren综合征 (ESS) 是一种淋巴细胞特异蛋白-1 (LSP1) 是一种淋巴细胞特异蛋白.主要Sjögren综合征 (pSS) 是一个主要的疾病.在Th17细胞中.

更多相关视频

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.